What is Planatome?
Founded in 2017 and headquartered in Phoenix, Arizona, Planatome operates as a subsidiary of Entrepix Medical, dedicated to the optimization of surgical tools. The company specializes in the development of proprietary scalpel blade technology designed to enhance the precision and safety of medical procedures. By leveraging advanced manufacturing processes, Planatome aims to elevate the standard of existing surgical instruments, ensuring that clinicians have access to tools that deliver superior performance. Their market position is defined by a commitment to technological refinement, effectively bridging the gap between traditional surgical hardware and modern, high-performance medical requirements.
How much funding has Planatome raised?
Planatome has raised a total of $6M across 2 funding rounds:
Debt
$1M
Series A
$5M
Debt (2023): $1M, investors not publicly disclosed
Series A (2023): $5M, investors not publicly disclosed
Key Investors in Planatome
Undisclosed Investor
An undisclosed institutional investor providing strategic capital to support the scaling of medical technology enterprises.
Undisclosed Investor
An undisclosed venture firm specializing in early-stage medical device innovation and surgical hardware development.
Undisclosed Investor
An undisclosed strategic partner focused on enhancing clinical outcomes through investment in high-performance surgical tools.
What's next for Planatome?
With the recent infusion of capital, Planatome is well-positioned to accelerate its research and development initiatives, focusing on the commercial scaling of its proprietary blade technology. The company is expected to prioritize market penetration strategies, targeting healthcare systems that demand higher precision in surgical outcomes. As the firm transitions from its current development phase into a broader commercialization cycle, the strategic focus will likely shift toward expanding its manufacturing capacity and securing partnerships with major medical device distributors. This growth trajectory suggests a long-term commitment to establishing a new benchmark in surgical instrumentation, potentially disrupting legacy tool markets through superior engineering and clinical efficacy.
See full Planatome company page
